Clinical Trial Update: Z650 in Advanced Esophageal Squamous Cell Carcinoma With EGFR Over Expression or Gene Amplification [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for Z650 in advanced esophageal squamous cell carcinoma with EGFR overexpression or gene amplification completed phases 1 and 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Z650

Snippet

Sponsor: Sunshine Lake Pharma Co., Ltd. | Conditions: Esophageal Squamous Cell Carcinoma | Phase 1, Phase 2 | Status: COMPLETED